Kiessling, W. (1934). Biochem. Z. 273, 103. King, E. J. & Delory, G. E. (1939). Biochem. J. 33, 1185. King, H. & Pyman, F. L. (1914). J. chem. Soc. 105, 1238. Kumler, W. D. & Eiler, J. J. (1943). J. Amer. chem. Soc. 65, 2355. Martin, J. B. & Doty, D. M. (1949). Analyt. Chem. 21, 965. Meyerhof, 0. & Suranyi, J. (1926). Biochem. Z. 178, 427. Morton, C. (1930). Quart. J. Pharm. 3, 438. Nimms, L. F...

Tripotassium dicitrato-bismuthate (TDB) has a topical action in the upper gastrointestinal tract. Absorption is minimal and the blood levels are therefore irrelevant to the assessment of bioavailability. TDB is however detectable in the stomach and duodenum by conventional electron microscopy. Following oral administration of two different formulations of TDB tablets to patients attending a gas...

Oxygen-isotope effect has been investigated in a recently discovered superconductor Sr0.4K0.6BiO3. This compound has a distorted perovskite structure and becomes superconducting at about 12 K. Upon replacing 16O with 18O by 60-80%, the Tc of the sample is shifted down by 0.32-0.50 K, corresponding to an isotope exponent of αO = 0.40(5). This isotope exponent is very close to that for a similar ...

Fifty patients with endoscopically proven gastric ulcers completed a one month double-blind randomised trial of tripotassium dicitrato bismuthate (TBD) (DeNol) compared with an identical placebo. Ulcer healing occurred in 18 (72%) of the 25 patients given TDB and in nine (36%) of the patients given placebo. The TDB group experienced significantly less pain than the placebo group. During a follo...

Tripotassium dicitrato-bismuthate (TDB) has a topical action in the upper gastrointestinal tract. Absorption is minimal and the blood levels are therefore irrelevant to the assessment of bioavailability. TDB is however detectable in the stomach and duodenum by conventional electron microscopy. Following oral administration of two different formulations of TDB tables to patients attending a gast...

BACKGROUND When metronidazole is used in bismuth-based or proton pump inhibitor-based triple therapy, the cure rate of Helicobacter pylori is usually high. However, metronidazole-resistant H. pylori strains, which are increasing in frequency, are a major cause of failed H. pylori eradication. AIM To evaluate the efficacy of non-metronidazole containing bismuth-based triple therapy for H. pylo...